Active traders and day traders have many stocks to choose from this Friday morning. We are tracking news and moves in shares of Acorda Therapeutics and Vivus Technologies.
Acorda Therapeutics (NASDAQ: ACOR) is down 17.36% to $23, relative to a 52-week range of $24.99-$40.48. A European medical agency recently turned down a multiple sclerosis treatment made by the company.
Vivus Technologies (NASDAQ: VVUS) is down 15% to $8.88, relative to a 52-week range of $4.69-$13.68. The FDA requested more data for their experimental obesity drug.
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
